E
Braxia Scientific Corp. BRAX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
E
Sell 3/14/2023Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index. The quick ratio declined from 1.68 to 1.3.
D
Sell 2/23/2023Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell 2/8/2023Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index.
D
Sell 1/6/2023Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 1/6/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell 12/22/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 12/22/2022 due to a decline in the volatility index.
D
Sell 12/2/2022Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 12/2/2022 due to an increase in the solvency index.
E
Sell 11/21/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 11/21/2022 due to a decline in the volatility index.
D
Sell 11/4/2022Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 11/4/2022 due to an increase in the volatility index.
E
Sell 10/19/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 10/19/2022 due to a decline in the volatility index.
D
Sell 10/4/2022Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 10/4/2022 due to an increase in the volatility index.
E
Sell 9/19/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 9/19/2022 due to a decline in the total return index and volatility index.
D
Sell 9/1/2022Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 9/1/2022 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0276 to -$0.0038, operating cash flow increased 53.73% from -$1.01M to -$469.3, and EBIT increased 48.54% from -$1.45M to -$747.4.
E
Sell 8/17/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 8/17/2022 due to a decline in the volatility index.
D
Sell 8/2/2022Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E on 8/2/2022 due to an increase in the growth index, volatility index and efficiency index. EBIT increased 27.09% from -$1.99M to -$1.45M, operating cash flow increased 25.66% from -$1.36M to -$1.01M, and total revenue increased 13.14% from $257.9 to $291.8.
E
Sell 7/20/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E from E+ on 7/20/2022 due to a decline in the volatility index.
E
Sell 6/2/2022Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to E+ from E on 6/2/2022 due to an increase in the volatility index.
E
Sell 5/16/2022Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E from E+ on 5/16/2022 due to a major decline in the solvency index, volatility index and growth index. Operating cash flow declined 175.86% from -$494.6 to -$1.36M, earnings per share declined from -$0.0081 to -$0.0119, and EBIT declined 46.33% from -$1.36M to -$1.99M.
E
Sell 11/23/2021Downgrade
Braxia Scientific Corp. (BRAX) was downgraded to E+ from D- on 11/23/2021 due to a decline in the volatility index and total return index.
D
Sell 11/8/2021Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to D- from E+ on 11/8/2021 due to an increase in the valuation index.
E
Sell 9/3/2021Upgraded
Braxia Scientific Corp. (BRAX) was upgraded to E+ from E on 9/3/2021 due to an increase in the valuation index.
E
Sell 5/6/2021None
Braxia Scientific Corp. (BRAX) was downgraded to E from U on 05/06/2021.
Weiss Ratings